EverEx partners with Novartis Korea to offer AI-powered musculoskeletal care
EverEx, a Korean digital musculoskeletal healthcare company, announced on Thursday a partnership with Novartis Korea to offer MORA Care, an AI-based musculoskeletal health management service, to patients requiring exercise therapy.
However, the specific patient groups targeted for this service were not disclosed due to contractual restrictions.
The collaboration leverages EverEx’s evidence-based rehabilitation exercise data and proof-of-concept (PoC) project experience to deliver a personalized, AI-driven service aimed at enhancing musculoskeletal health for patients in need of targeted interventions.
MORA Care provides personalized health management tailored to individual musculoskeletal needs. Through a mobile application, users complete an initial survey that generates customized rehabilitation exercise plans.
The app incorporates AI motion evaluation to objectively assess musculoskeletal conditions and offers subscription-based educational content to promote sustainable, healthy habits.
EverEx has validated the effectiveness of its tailored health management approach through POC projects targeting corporate employees and general users.
The results revealed high levels of satisfaction, with 81 percent of participating companies expressing satisfaction and an 88 percent recommendation rate among employees. Among general users, approximately 94 percent reported satisfaction with their assigned exercise regimens.
Based on this accumulated data, EverEx plans to expand its services to offer professional health management solutions for patients requiring rehabilitation exercises.
“This partnership is a meaningful result of the ongoing relationship we’ve built since being selected in 2022 for the Health X Challenge Seoul hosted by Novartis,” EverEx CEO Yoon Chan. “Through EverEx’s AI technology and rehabilitation exercise data, we aim to improve the quality of life for patients.”
Meanwhile, EverEx offers four core solutions under its musculoskeletal rehabilitation therapy brand MORA. The company aims to commercialize MORA Care for corporate employees by 2025.